Together these findings support that pharmacological targeting of NBCn1 with inhibitory antibodies decelerates cancer growth, specifically under acidic conditions, through G2/M-phase cell cycle accumulation and enhanced apoptosis. Here, SLC4A7 is linked to cancer.